Print/View WholeSend FeedbackRate this page:
Pharmacotherapy of pervasive developmental disorders in children and adolescents.
This page provides detailed information about this publication. Please click on any text which is underlined to find more information.
Title: Pharmacotherapy of pervasive developmental disorders in children and adolescents.
Volume: 18
Issue: 14
Page(s): pp. 1031-1052
Efficacy Study/Review:
Yes Keywords:
Adrenergic Agonists,
Amantadine Hydrochloride,
Anger/Aggression,
Antidepressants,
Antipsychotics,
Autism,
Buspirone,
Challenging / Disruptive Behaviour,
Citalopram,
Clomipramine,
Clonidine,
Clozapine,
Depression,
Fluoxetine,
Fluvoxamine,
Glutamate,
Guanfacine,
Haloperidol,
Hyperactivity,
Intervention,
Lamotrigine,
Medication,
Mental Health,
Mirtazapine,
Mood Stabilisers,
Naloxone,
Naltrexone,
Obsessive Compulsive Disorder,
Olanzapine,
Opioid Antagonists,
Paroxetine,
Pimozide,
Psychoactive,
Quetiapine,
Repetitive and Restricted Behaviour,
Risperidone,
Secretin,
Selective Noradrenaline Re-Uptake Inhibitor,
Selective Serotonin and Norepinephrine Reuptake Inhibitors,
Selective Serotonin Reuptake Inhibitors,
Self Injurious Behaviour,
Sertraline,
Stimulants,
Venlafaxine,
Ziprasidone
Please note that Research Autism is unable to supply publications unless we are listed as the publisher. However, if you are a UK resident you may be able to obtain them from your local public library, your college library, the National Autistic Society's Information Centre (Open in new window) or direct from the publisher.
Publications Database |
Search Publications |
Publications Help
Back To Top